Insider Trading activities of Bluebird Bio, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bluebird Bio, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bluebird Bio, Inc. since year 2005. Table 2 shows the detailed insider transactions of Bluebird Bio, Inc. since 2005. The reporting company's ticker symbol is BLUE. The reporting company's CIK number is 1293971.
The total value of stock buying since 2005 is $900,936.
The total value of stock sales since 2005 is $201,222,264.
The total value of stock option exercises since 2005 is $7,872,982.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Bluebird Bio, Inc. (BLUE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 0 $0 66,518 $8,598,816 49,382 $413,343
2017-08 0 $0 87,950 $9,797,700 35,950 $230,302
2017-07 0 $0 15,263 $1,595,896 17,456 $338,847
2017-06 0 $0 75,590 $7,890,592 45,986 $987,948
2017-05 0 $0 7,750 $670,055 7,000 $55,199
2017-04 0 $0 7,250 $646,368 11,000 $103,890
2017-03 0 $0 43,185 $3,903,048 42,774 $495,201
2017-02 0 $0 14,723 $1,169,021 10,000 $171,288
2017-01 0 $0 25,810 $1,823,876 20,000 $293,216
2016-10 0 $0 416 $27,870 416 $9,395
2016-09 0 $0 416 $24,544 416 $9,395
2016-08 0 $0 416 $24,544 416 $9,395
2016-07 0 $0 6,719 $332,095 3,912 $67,857
2016-06 0 $0 3,931 $155,945 20,826 $77,290
2016-05 0 $0 1,000 $38,729 1,000 $2,090
2016-04 0 $0 1,000 $49,630 1,000 $2,090
2016-03 0 $0 1,000 $46,366 1,000 $2,090
2016-02 0 $0 1,000 $45,176 1,000 $2,090
2016-01 0 $0 1,000 $44,392 1,000 $2,090
2015-12 9,682 $501,062 1,416 $92,297 72,574 $326,578
2015-11 0 $0 2,416 $174,677 2,416 $13,575
2015-10 0 $0 21,416 $1,905,528 21,416 $155,473
2015-09 0 $0 150,416 $20,189,663 150,416 $856,510
2015-08 0 $0 171,416 $24,507,739 171,416 $578,306
2015-07 0 $0 19,542 $3,133,580 18,416 $149,215
2015-06 0 $0 30,416 $5,677,588 30,416 $448,675
2015-05 0 $0 67,416 $10,523,276 67,416 $461,230
2015-04 0 $0 85,998 $10,500,314 85,998 $292,148
2015-03 0 $0 24,500 $2,669,933 24,500 $255,605
2015-02 0 $0 14,500 $1,283,044 14,500 $30,289
2015-01 0 $0 48,250 $4,493,426 48,250 $160,522
2014-12 3,528 $299,880 86,751 $5,235,273 79,500 $145,562
2014-11 0 $0 35,500 $1,478,228 10,500 $21,932
2014-10 0 $0 318,423 $11,298,711 45,018 $94,086
2014-09 0 $0 318,595 $11,672,957 28,500 $39,044
2014-08 0 $0 20,800 $718,791 10,500 $21,944
2014-07 2,941 $99,994 32,783 $1,255,780 10,500 $21,944
2014-06 0 $0 93,500 $3,358,237 28,500 $39,045
2014-05 0 $0 15,000 $294,980 126,266 $263,895
2014-04 0 $0 15,000 $332,399 10,000 $20,900
2014-03 0 $0 29,500 $737,365 24,500 $42,085
2014-02 0 $0 24,000 $512,944 19,000 $39,709
2014-01 0 $0 1,837,500 $41,568,121 38,500 $69,065
2013-12 0 $0 35,000 $722,750 35,000 $52,629

Table 2. Detailed insider stock purchases, sales, and option exercises of Bluebird Bio, Inc. insiders (BLUE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-14 Maraganore John (Director) Sale 18,868 131.50 2,481,236
2017-09-14 Maraganore John (Director) Option Ex 18,868 2.09 39,434
2017-09-12 Vachon Mark (Director) Sale 6,000 126.57 759,444
2017-09-12 Vachon Mark (Director) Option Ex 6,000 30.47 182,820
2017-09-11 Walsh Jeffrey T. (Chief Financial) Sale 4,900 125.94 617,086
2017-09-11 Walsh Jeffrey T. (Chief Financial) Option Ex 4,900 5.50 26,950
2017-09-01 Davidson David (Chief Medical Officer) Sale 12,000 127.59 1,531,092
2017-09-01 Davidson David (Chief Medical Officer) Option Ex 12,000 5.50 66,000
2017-09-01 Leschly Nick (President and CEO) Sale 22,500 130.04 2,925,990
2017-09-01 Leschly Nick (President and CEO) Option Ex 6,364 5.50 35,002
2017-09-01 Gregory Philip D (Chief Scientific Officer) Sale 2,250 126.21 283,968
2017-09-01 Gregory Philip D (Chief Scientific Officer) Option Ex 1,250 50.51 63,137
2017-08-31 Leschly Nick (President and CEO) Sale 24,333 115.09 2,800,460
2017-08-31 Walsh Jeffrey T. (Chief Financial) Sale 12,000 125.01 1,500,096
2017-08-31 Walsh Jeffrey T. (Chief Financial) Option Ex 12,000 5.50 66,000
2017-08-31 Schenkein David P (Director) Sale 2,000 115.07 230,146
2017-08-31 Schenkein David P (Director) Option Ex 2,000 8.16 16,312
2017-08-31 Lynch Daniel (Director) Sale 500 120.00 60,000
2017-08-31 Lynch Daniel (Director) Option Ex 500 5.50 2,750
2017-08-30 Leschly Nick (President and CEO) Sale 25,667 115.18 2,956,299
2017-08-28 Walsh Jeffrey T. (Chief Financial) Sale 1,250 107.06 133,826
2017-08-28 Walsh Jeffrey T. (Chief Financial) Option Ex 1,250 5.50 6,875
2017-08-24 Maraganore John (Director) Sale 11,085 95.72 1,061,100
2017-08-24 Maraganore John (Director) Option Ex 13,839 2.09 28,923
2017-08-14 Mandell James (Director) Sale 1,000 95.95 95,950
2017-08-10 Walsh Jeffrey T. (Chief Financial) Sale 1,250 95.41 119,265
2017-08-10 Walsh Jeffrey T. (Chief Financial) Option Ex 1,250 5.50 6,875
2017-08-07 Gregory Philip D (Chief Scientific Officer) Sale 750 99.00 74,250
2017-08-07 Gregory Philip D (Chief Scientific Officer) Option Ex 500 50.51 25,255
2017-08-04 Sullivan Eric (Principal Accounting Officer) Sale 445 95.21 42,369
2017-08-04 Sullivan Eric (Principal Accounting Officer) Option Ex 445 53.41 23,765
2017-08-03 Sullivan Eric (Principal Accounting Officer) Sale 416 92.35 38,417
2017-08-03 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2017-08-02 Maraganore John (Director) Sale 2,754 96.74 266,424
2017-08-01 Davidson David (Chief Medical Officer) Sale 3,000 93.13 279,384
2017-08-01 Davidson David (Chief Medical Officer) Option Ex 3,000 2.09 6,270
2017-08-01 Gregory Philip D (Chief Scientific Officer) Sale 1,500 93.14 139,714
2017-08-01 Gregory Philip D (Chief Scientific Officer) Option Ex 750 50.51 37,882
2017-07-10 Walsh Jeffrey T. (Chief Financial) Sale 2,500 100.19 250,470
2017-07-10 Walsh Jeffrey T. (Chief Financial) Option Ex 2,500 5.50 13,750
2017-07-07 Davidson David (Chief Medical Officer) Sale 1,200 100.77 120,918
2017-07-06 Cole Jason (Chief Legal Officer) Option Ex 5,126 22.53 115,488
2017-07-06 Gregory Philip D (Chief Scientific Officer) Sale 2,250 103.83 233,615
2017-07-06 Gregory Philip D (Chief Scientific Officer) Option Ex 1,250 50.51 63,137
2017-07-05 Sullivan Eric (Principal Accounting Officer) Sale 4,313 107.26 462,608
2017-07-05 Sullivan Eric (Principal Accounting Officer) Option Ex 3,580 37.99 136,022
2017-07-05 Davidson David (Chief Medical Officer) Sale 5,000 105.66 528,285
2017-07-05 Davidson David (Chief Medical Officer) Option Ex 5,000 2.09 10,450
2017-06-29 Sullivan Eric (Principal Accounting Officer) Sale 6,787 109.07 740,230
2017-06-29 Sullivan Eric (Principal Accounting Officer) Option Ex 6,728 31.89 214,576
2017-06-27 Leschly Nick (President and CEO) Sale 25,000 108.09 2,702,225
2017-06-23 Lynch Daniel (Director) Sale 4,000 109.50 438,016
2017-06-23 Lynch Daniel (Director) Option Ex 4,000 3.79 15,172
2017-06-20 Lynch Daniel (Director) Sale 2,500 120.03 300,070
2017-06-20 Lynch Daniel (Director) Option Ex 2,500 2.09 5,215
2017-06-16 Gregory Philip D (Chief Scientific Officer) Sale 3,295 109.53 360,914
2017-06-12 Walsh Jeffrey T. (Chief Financial) Sale 2,500 110.26 275,650
2017-06-12 Walsh Jeffrey T. (Chief Financial) Option Ex 2,500 2.09 5,215
2017-06-08 Lynch Daniel (Director) Sale 2,500 110.19 275,487
2017-06-08 Lynch Daniel (Director) Option Ex 2,500 2.09 5,215
2017-06-07 Cole Jason (Chief Legal Officer) Sale 435 100.05 43,521
2017-06-07 Cole Jason (Chief Legal Officer) Option Ex 435 50.51 21,971
2017-06-06 Walsh Jeffrey T. (Chief Financial) Sale 2,500 100.05 250,135
2017-06-06 Walsh Jeffrey T. (Chief Financial) Option Ex 2,500 2.09 5,215
2017-06-06 Cole Jason (Chief Legal Officer) Sale 16,810 100.22 1,684,698
2017-06-06 Cole Jason (Chief Legal Officer) Option Ex 16,810 36.52 613,901
2017-06-06 Gregory Philip D (Chief Scientific Officer) Sale 1,500 99.04 148,560
2017-06-06 Gregory Philip D (Chief Scientific Officer) Option Ex 1,000 50.51 50,510
2017-06-06 Lynch Daniel (Director) Sale 2,263 100.14 226,621
2017-06-06 Lynch Daniel (Director) Option Ex 2,263 2.09 4,720
2017-06-05 Davidson David (Chief Medical Officer) Sale 1,000 90.00 90,002
2017-06-05 Davidson David (Chief Medical Officer) Option Ex 1,000 2.09 2,090
2017-06-05 Lynch Daniel (Director) Sale 1,000 90.00 90,002
2017-06-05 Lynch Daniel (Director) Option Ex 1,000 2.09 2,086
2017-06-01 Davidson David (Chief Medical Officer) Sale 2,000 75.42 150,850
2017-06-01 Davidson David (Chief Medical Officer) Option Ex 2,000 2.09 4,180
2017-06-01 Gregory Philip D (Chief Scientific Officer) Sale 1,500 75.74 113,611
2017-06-01 Gregory Philip D (Chief Scientific Officer) Option Ex 750 50.51 37,882
2017-05-25 Lynch Daniel (Director) Sale 2,000 80.00 160,002
2017-05-25 Lynch Daniel (Director) Option Ex 2,000 2.09 4,172
2017-05-10 Walsh Jeffrey T. (Chief Financial) Sale 1,250 89.10 111,377
2017-05-10 Walsh Jeffrey T. (Chief Financial) Option Ex 1,250 5.50 6,875
2017-05-01 Davidson David (Chief Medical Officer) Sale 3,000 88.74 266,220
2017-05-01 Davidson David (Chief Medical Officer) Option Ex 3,000 2.09 6,270
2017-05-01 Gregory Philip D (Chief Scientific Officer) Sale 1,500 88.30 132,456
2017-05-01 Gregory Philip D (Chief Scientific Officer) Option Ex 750 50.51 37,882
2017-04-27 Lynch Daniel (Director) Sale 1,000 90.01 90,010
2017-04-27 Lynch Daniel (Director) Option Ex 1,000 2.09 2,086
2017-04-26 Cole Jason (Chief Legal Officer) Option Ex 3,750 22.53 84,487
2017-04-25 Lynch Daniel (Director) Sale 2,000 86.75 173,500
2017-04-25 Lynch Daniel (Director) Option Ex 2,000 2.09 4,172
2017-04-10 Walsh Jeffrey T. (Chief Financial) Sale 1,250 87.38 109,225
2017-04-10 Walsh Jeffrey T. (Chief Financial) Option Ex 1,250 5.50 6,875
2017-04-03 Davidson David (Chief Medical Officer) Sale 3,000 91.21 273,633
2017-04-03 Davidson David (Chief Medical Officer) Option Ex 3,000 2.09 6,270
2017-03-27 Lynch Daniel (Director) Sale 1,000 90.00 90,000
2017-03-27 Lynch Daniel (Director) Option Ex 1,000 2.09 2,086
2017-03-24 Lynch Daniel (Director) Sale 2,000 87.37 174,732
2017-03-24 Lynch Daniel (Director) Option Ex 2,000 2.09 4,172
2017-03-16 Sullivan Eric (Principal Accounting Officer) Sale 411 99.00 40,689
2017-03-16 Walsh Jeffrey T. (Chief Financial) Sale 3,543 100.07 354,562
2017-03-16 Walsh Jeffrey T. (Chief Financial) Option Ex 3,543 3.79 13,445
2017-03-16 Cole Jason (Chief Legal Officer) Sale 4,930 100.07 493,364
2017-03-16 Cole Jason (Chief Legal Officer) Option Ex 4,930 22.53 111,072
2017-03-16 Lynch Daniel (Director) Sale 237 100.07 23,717
2017-03-16 Lynch Daniel (Director) Option Ex 237 2.09 494
2017-03-03 Maraganore John (Director) Sale 13,839 85.02 1,176,647
2017-03-03 Maraganore John (Director) Option Ex 13,839 3.22 44,616
2017-03-01 Davidson David (Chief Medical Officer) Sale 5,000 89.83 449,155
2017-03-01 Davidson David (Chief Medical Officer) Option Ex 5,000 2.09 10,450
2017-03-01 Schenkein David P (Director) Sale 5,000 89.53 447,635
2017-03-01 Schenkein David P (Director) Option Ex 5,000 8.16 40,780
2017-03-01 Cole Jason (Chief Legal Officer) Sale 5,225 90.32 471,911
2017-03-01 Cole Jason (Chief Legal Officer) Option Ex 5,225 50.51 263,914
2017-03-01 Lynch Daniel (Director) Sale 2,000 90.32 180,636
2017-03-01 Lynch Daniel (Director) Option Ex 2,000 2.09 4,172
2017-02-28 Sullivan Eric (Principal Accounting Officer) Sale 285 89.00 25,365
2017-02-15 Mandell James (Director) Sale 1,050 80.22 84,235
2017-02-15 Mandell James (Director) Option Ex 1,050 25.16 26,418
2017-02-15 Cole Jason (Chief Legal Officer) Sale 666 80.22 53,429
2017-02-15 Lynch Daniel (Director) Sale 150 80.22 12,033
2017-02-15 Lynch Daniel (Director) Option Ex 150 2.09 312
2017-02-14 Mandell James (Director) Sale 5,950 80.01 476,077
2017-02-14 Mandell James (Director) Option Ex 5,950 23.30 138,605
2017-02-14 Cole Jason (Chief Legal Officer) Sale 3,772 80.01 301,809
2017-02-14 Lynch Daniel (Director) Sale 850 80.01 68,011
2017-02-14 Lynch Daniel (Director) Option Ex 850 2.09 1,773
2017-02-01 Davidson David (Chief Medical Officer) Sale 2,000 74.03 148,062
2017-02-01 Davidson David (Chief Medical Officer) Option Ex 2,000 2.09 4,180
2017-01-31 Mandell James (Director) Sale 8,000 75.04 600,320
2017-01-31 Mandell James (Director) Option Ex 8,000 21.43 171,440
2017-01-27 Mandell James (Director) Sale 5,000 70.10 350,500
2017-01-27 Mandell James (Director) Option Ex 5,000 21.43 107,150
2017-01-27 Davidson David (Chief Medical Officer) Sale 6,000 68.85 413,117
2017-01-27 Davidson David (Chief Medical Officer) Option Ex 6,000 2.09 12,540
2017-01-27 Lynch Daniel (Director) Sale 1,000 70.09 70,092
2017-01-27 Lynch Daniel (Director) Option Ex 1,000 2.09 2,086
2017-01-05 Sullivan Eric (Principal Accounting Officer) Sale 229 67.10 15,365
2017-01-05 Davidson David (Chief Medical Officer) Sale 923 67.10 61,933
2017-01-05 Leschly Nick (President and CEO) Sale 2,024 67.10 135,810
2017-01-05 Walsh Jeffrey T. (Chief Financial) Sale 1,295 67.10 86,894
2017-01-05 Cole Jason (Chief Legal Officer) Sale 549 67.10 36,837
2017-01-05 Gregory Philip D (Chief Scientific Officer) Sale 790 67.10 53,008
2016-10-03 Sullivan Eric (Principal Accounting Officer) Sale 416 67.00 27,870
2016-10-03 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2016-09-13 Sullivan Eric (Principal Accounting Officer) Sale 416 59.00 24,544
2016-09-13 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2016-08-03 Sullivan Eric (Principal Accounting Officer) Sale 416 59.00 24,544
2016-08-03 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2016-07-27 Sullivan Eric (Principal Accounting Officer) Sale 2,912 55.01 160,177
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of BLUE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bluebird Bio, Inc. (symbol BLUE, CIK number 1293971) see the Securities and Exchange Commission (SEC) website.